Collaboration Agreement Sample Contracts
Exhibit 10.8 Collaboration Agreement Section 1: General Intention China Netcom of GuangXi Province ("Party A") and Beijing Candidsoft Technology Co. Ltd. ("Party B"), in accordance with People's Republic of China's Agreement Law and other regulations...Collaboration Agreement • August 6th, 2008 • China Voice Holding Corp.
Standard Contracts
BETWEENCollaboration Agreement • June 5th, 2007 • Transition Therapeutics Inc. • New York
ANDCollaboration Agreement • January 18th, 2006 • pSivida LTD • Laboratory analytical instruments • Georgia
Dated _________________________201[] MODEL COLLABORATION AGREEMENT 1Collaboration Agreement • September 21st, 2024
[The Technology Strategy Board has announced its intention to make a grant in respect of that project, subject to the terms of the offer letter referred to below, and subject to the parties entering into an agreement governing their collaboration.]
GM VCSE Accord AgreementCollaboration Agreement • March 25th, 2022
This is a three-way collaboration agreement between the Greater Manchester Combined Authority and the Greater Manchester Health and Social Care Partnership and the GM Voluntary, Community and Social Enterprise (VCSE) Sector* represented by the GM VCSE Leadership Group, based in a relationship of mutual trust, working together, and sharing responsibility. The purpose of this Accord is to further develop how we work together to improve outcomes for Greater Manchester’s communities and citizens.
COLLABORATION AGREEMENTCollaboration Agreement • August 31st, 2021 • Liverpool
EXHIBIT 10.18 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS([**]), HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED...Collaboration Agreement • June 24th, 2004 • Viacell Inc • Services-commercial physical & biological research • New York
Agreement On Electronic Collaboration Page: 10 - 10 Version 3.2 Date: 04.02.2022Collaboration Agreement • August 14th, 2023
This Collaboration Agreement applies to the conduct of electronic interaction and intends to harmonize their mutual expectations and ensure satisfactory progress on implementation of the e-commerce solution.
A Collaboration Agreement – National Counter Terrorism Police Services Version 2019 v.1Collaboration Agreement • August 5th, 2019 • England and Wales
National Police Collaboration Agreement Relating to Counter Terrorism Activities Made Under Section 22A of the Police Act 1996
Collaboration Agreement withinCollaboration Agreement • May 11th, 2022 • Marche
Istituto Superiore di Sanità, with registered office in Rome Viale Regina Elena, 299 00161 Italy represented by the President Prof. Silvio Brusaferro (hereinafter: Beneficiary)
EXHIBIT 10.13 COLLABORATION AGREEMENTCollaboration Agreement • March 22nd, 2005 • BioNumerik Pharmaceuticals, Inc. • Services-commercial physical & biological research
EX-10.4 9 dex104.htm COLLABORATION AND LICENSE AGREEMENT Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AGREEMENTCollaboration Agreement • May 5th, 2020 • Massachusetts
THIS COLLABORATION AGREEMENT (the “Agreement”) is entered into as of the 24th day of February, 2006 (the “Effective Date”), by and between Infinity Pharmaceuticals, Inc., a Delaware corporation having an office at 780 Memorial Drive, Cambridge, Massachusetts 02139 (“Infinity”), and Novartis Institutes for BioMedical Research, Inc., a Delaware corporation having an office at 250 Massachusetts Avenue, Cambridge, Massachusetts 02139 (“Novartis”).
AGREEMENT FOR THE COLLABORATION BETWEEN CELLTECH R & D LTD and UCB FARCHIM S.A. *CONFIDENTIAL MATERIAL HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION.Collaboration Agreement • July 8th, 2004 • Celltech Group PLC • Pharmaceutical preparations • England
Scope Collaboration between Celltech and UCB, on a co-exclusive basis (“Co-exclusive” meaning UCB and Celltech only and limited to their respective rights hereunder), for the further development, manufacture and commercialisation of the Product initially for the treatment of rheumatoid arthritis (‘RA’) and Crohn’s disease in humans and for the treatment of any other agreed indications in the Field. The co-exclusive collaboration includes the right to appoint any third party including but not limited to affiliated companies as distributors, except for Japan where UCB shall have the right to appoint sub-licensees.
Tunbridge Wells Agreement Agreement of collaboration and cooperation between Tunbridge Wells Borough Council and the Local Councils which make up the Borough ofTunbridge WellsCollaboration Agreement • December 22nd, 2020
This Agreement sets out the terms for a productive relationship between Tunbridge Wells Borough Council (the Borough Council) and all Parish and Town Councils in the Tunbridge Wells area (referred to in this document as Local Councils).
AMENDED AND RESTATED COLLABORATION AGREEMENTCollaboration Agreement • August 9th, 2019 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED COLLABORATION AGREEMENT (the “Agreement”) is dated as of June 19, 2019 by and between Checkpoint Therapeutics, Inc., a Delaware corporation organized having its place of business at 2 Gansevoort Street, New York, NY 10014 (“CTI”), and TG Therapeutics, Inc. located at 2 Gansevoort Street, New York, NY 10014 (“TGTX”). CTI, on the one hand, and TGTX, on the other hand, shall each be referred to herein as a “Party” or, collectively, as the “Parties.”
COLLABORATION AGREEMENT Memorandum of Understanding Between: Open Food Web Foundation Ltd (“Open Food Foundation”) (hereinafter referred to as "Collaborator A" further referred to as "OFN ")Collaboration Agreement • January 8th, 2016
THIS AGREEMENT is made and is effective from this X day of September 2015, notwithstanding the signature date of this agreement.
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles VaccineCollaboration Agreement • October 25th, 2022
Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects people all over the world Product candidates will be based on BioNTech’s proprietary mRNA technology and on Pfizer’s antigen technology Clinical trials are expected to start in the second half of 2022 BioNTech will receive $225 million upfront, including an upfront cash payment of $75 million and an equity investment of
COLLABORATION AGREEMENT FOR THE PROVISION OF FIREARMS AND EXPLOSIVES LICENSING SERVICECollaboration Agreement • March 31st, 2015
INTRODUCTIONCollaboration Agreement • May 29th, 2024
The purpose of this 2024-2026 PCN Grouping Template Collaboration Agreement for practices delivering COVID-19 vaccinations and / or synergistic seasonal influenza1 vaccinations and / or co-administrated COVID-19 and seasonal influenza vaccinations (this “Agreement”) is to support the delivery of the individual and collective responsibilities of the Collaborating Practices as part of the COVID-19 vaccination programme as set out in the General Practice Enhanced Service Specification (COVID-19 vaccination programme: 1 September 2024 to 31 March 2026) (the “ES”) (as amended from time to time) [and:
Collaboration Agreement between Institute of Grassland and Environmental Research and Ceres, Inc.Collaboration Agreement • January 25th, 2012 • Ceres, Inc. • Agricultural production-crops • New York
THIS AGREEMENT is made this 1st day of April, 2007 (“Effective Date”), by and between INSTITUTE OF GRASSLAND AND ENVIRONMENTAL RESEARCH (“IGER”), a company limited by guarantee, registered in England No. 473456 and a registered Charity No. 272150, having an office at Plas Gogerddan, Aberystwyth, Ceredigion, SY23 3EB, United Kingdom and CERES, INC. (“CERES”), a Delaware corporation, having an office at 1535 Rancho Conejo Blvd., Thousand Oaks, California 91320, United States of America.
EX-10.31 54 dex1031.htm COLLABORATION AGREEMENT ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and Rule 406 of the Securities Act of 1933, as...Collaboration Agreement • May 5th, 2020 • California
This Collaboration Agreement (the “Agreement”) is entered into as of September 14, 2010 (the “Effective Date”) by and between AMBIT BIOSCIENCES CORPORATION, a Delaware corporation with its principal place of business located at 4215 Sorrento Valley Blvd., San Diego, California 92121 (“Ambit”), and GENOPTIX, INC., a Delaware corporation with its principal place of business located at 1811 Aston Avenue, Carlsbad, California 92008 (“Genoptix”). Ambit and Genoptix are also herein designated individually as “Party” and collectively as “Parties.”
Department of Energy § 603.530Collaboration Agreement • February 3rd, 2020
MASSACHUSETTS HOMEOWNER ASSISTANCE FUND COLLABORATION AGREEMENTCollaboration Agreement • April 13th, 2022
COLLABORATION AGREEMENT made this (“Agreement Date”) between (“Servicer”) and the Commonwealth of Massachusetts acting by and through the Massachusetts Housing Partnership (“Program Administrator”).
DATE: 7 MAY 2014 WALSALL METROPOLITAN BOROUGH COUNCIL DUDLEY METROPOLITAN BOROUGH COUNCIL SANDWELL METROPOLITAN BOROUGH COUNCIL WOLVERHAMPTON CITY COUNCIL -and- BLACK COUNTRY CONSORTIUM LIMITED COLLABORATION AGREEMENT in relation toCollaboration Agreement • October 23rd, 2018
BLACK COUNTRY CONSORTIUM LIMITED (Company Registration number 05159791) whose registered office is at The Deckhouse, Waterfront West, Dudley Road, Brierly Hill, DY5 1LW (“BCC”)
COLLABORATION AGREEMENT between PACIFIC BIOSCIENCES OF CALIFORNIA, INC. and GEN-PROBE INCORPORATED Dated as of June 15, 2010Collaboration Agreement • November 3rd, 2010 • Gen Probe Inc • Surgical & medical instruments & apparatus • California
THIS COLLABORATION AGREEMENT (the “Agreement”) is entered into between Pacific Biosciences of California, Inc., a Delaware corporation (“PacBio”), having a place of business at 1505 Adams Drive, Menlo Park, California 94025 and Gen-Probe Incorporated, a Delaware corporation (“Gen-Probe”), having a place of business at 10210 Genetic Center Drive, San Diego, California 92121. PacBio and Gen-Probe may each sometimes be referred to herein as a “party” and collectively as the “parties.”
BACKGROUNDCollaboration Agreement • August 14th, 2003 • Caliper Technologies Corp • Laboratory analytical instruments • California
Date December 2019Collaboration Agreement • April 29th, 2020 • England and Wales
COLLABORATION AGREEMENTCollaboration Agreement • January 8th, 2014 • Biocept Inc • Services-medical laboratories • California
THIS COLLABORATION AGREEMENT (the “Agreement”) is entered into as of November 2, 2012 (the “Effective Date”) by and between BIOCEPT, INC., a California corporation having an address of 5810 Nancy Ridge Drive, Suite 150, San Diego, CA 92121 (“Biocept”), and LIFE TECHNOLOGIES CORPORATION, a Delaware corporation having an address of 5791 Van Allen Way, Carlsbad, California 92008 (“Life Technologies”).
REAL-WORLD EPIDEMIOLOGICAL EVIDENCE COLLABORATION AGREEMENTCollaboration Agreement • February 7th, 2021
dated as of January 6, 2021 (this “Agreement”) by and between the Israeli Ministry of Health, acting on its own behalf and on behalf of the State of Israel (the “MoH”), and Pfizer Inc., a Delaware corporation (together with its Affiliates, “PFIZER”) (each, a “Party” and, collectively, the “Parties”).
pTrac Siemens FW contractCollaboration Agreement • May 12th, 2006 • 2-Track Global, Inc. • Search, detection, navagation, guidance, aeronautical sys • England
THIS AGREEMENT is made the 10th day of May, 2006 BETWEEN: 1. 2-TRACK LIMITED (registered in England under number 4560034) whose registered office is at 6th Floor, Holborn Hall, 100 Gray's Inn Road, London, WC1X 8BY ("2-Track"); and 2. CHENGHOLIN TECHNOLOGY a company registered under the laws of Taiwan whose principal place of business is at 10F, No.25, Lane 155, BeiShen Road Sec 3, Shen Keng 222, Taipei, Taiwan ("ChengHolin"). BACKGROUND A. 2-Track is the proprietor of the innovative CONDOR tracking and monitoring technology. B. ChengHolin as part of its business activities designs and manufactures telematics components for use with tracking and monitoring solutions. C. 2-Track and ChengHolin wish to collaborate on a Project to further develop the CONDOR technology by developing a solution for tracking primarily Fleet vehicle and associated assets known as “CONDOR FMS” as more particularly described in Schedule 1 to this Agreement. D. The parties intend by this A
BACKGROUNDCollaboration Agreement • July 18th, 2003 • Genvec Inc • Pharmaceutical preparations • California
COLLABORATION AGREEMENTCollaboration Agreement • September 6th, 2021 • England and Wales
Collaboration Agreement between a patient advocate and a pharmaceutical companyCollaboration Agreement • November 18th, 2021
This is a reference agreement, specific for Collaboration Agreements, that should be adapted according to the needs of the users. It is based on the “Guiding Principles on Reasonable Agreements between Patient Advocates and Pharmaceutical Companies”, provided by the WECAN project on “Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies”, for the most recent version and more information about the guiding principles, please visit www.wecanadvocate.eu/rapp
Collaboration Agreement SummaryCollaboration Agreement • June 3rd, 2019
NOW THEREFORE this Agreement witnesses that the parties mutually covenant and agree as follows: 3 PART 1Collaboration Agreement • July 3rd, 2000 • Graftech Inc • Electrical industrial apparatus • British Columbia
